Cargando…

Hemadsorption: A New Therapeutic Option for Selected Cases of Bromazepam Intoxication

Benzodiazepine ingestion is frequent in patients admitted to ICU for intoxications. Generally, a supportive approach by securing the airway, breathing, and circulation is sufficient. Flumazenil is a well-known antidote for benzodiazepines but does not influence its elimination. Following preclinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Mekeirele, Michaël, Verheyen, Silke, Van Lancker, Ruth, Wuyts, Stephanie, Balthazar, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743138/
https://www.ncbi.nlm.nih.gov/pubmed/36518360
http://dx.doi.org/10.1159/000526323
Descripción
Sumario:Benzodiazepine ingestion is frequent in patients admitted to ICU for intoxications. Generally, a supportive approach by securing the airway, breathing, and circulation is sufficient. Flumazenil is a well-known antidote for benzodiazepines but does not influence its elimination. Following preclinical data, we applied for the first time in humans a hemadsorption filter in a patient with a bromazepam intoxication. This technique proved to be effective in eliminating bromazepam in a patient with CHILD-C cirrhosis. We conclude that hemadsorption is a viable option to reduce length of ICU stay or intubation in slow metabolizers without contraindications.